BACKGROUND: The American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) was started in 2004. Presently, 58% of the 198 hospitals participating in ACS-NSQIP are academic or teaching hospitals. In 2008, ACS-NSQIP initiated a number of changes and made risk-adjusted data available for use by participating hospitals. This analysis explores the ACS-NSQIP database for utility in developing hepato-pancreato-biliary (HPB) surgery-specific outcomes (HPB-NSQIP). METHODS: The ACS-NSQIP Participant Use File was queried for patient demographics and outcomes for 49 HPB operations from 1 January 2005 through 31 December 2007. The procedures included six hepatic, 16 pancreatic and 23 complex biliary operations. Four laparoscopic or open cholecystectomy operations were also studied. Risk-adjusted probabilities for morbidity and mortality were compared with observed rates for each operation. RESULTS: During this 36-month period, data were accumulated on 9723 patients who underwent major HPB surgery, as well as on 44,189 who received cholecystectomies. The major HPB operations included 2847 hepatic (29%), 5074 pancreatic (52%) and 1802 complex biliary (19%) procedures. Patients undergoing hepatic resections were more likely to have metastatic disease (42%) and recent chemotherapy (7%), whereas those undergoing complex biliary procedures were more likely to have significant weight loss (20%), diabetes (13%) and ascites (5%). Morbidity was high for hepatic, pancreatic and complex biliary operations (20.1%, 32.4% and 21.2%, respectively), whereas mortality was low (2.3%, 2.7% and 2.7%, respectively). Compared with laparoscopic cholecystectomy, the open operation was associated with higher rates of morbidity (19.2% vs. 6.0%) and mortality (2.5% vs. 0.3%). The ratios between observed and expected morbidity and mortality rates were <1.0 for hepatic, pancreatic and biliary operations. CONCLUSIONS: These data suggest that HPB operations performed at ACS-NSQIP hospitals have acceptable outcomes. However, the creation of an HPB-NSQIP has the potential to improve quality, provide risk-adjusted registries with HPB-specific data and facilitate multi-institutional clinical trials.
BACKGROUND: The American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) was started in 2004. Presently, 58% of the 198 hospitals participating in ACS-NSQIP are academic or teaching hospitals. In 2008, ACS-NSQIP initiated a number of changes and made risk-adjusted data available for use by participating hospitals. This analysis explores the ACS-NSQIP database for utility in developing hepato-pancreato-biliary (HPB) surgery-specific outcomes (HPB-NSQIP). METHODS: The ACS-NSQIP Participant Use File was queried for patient demographics and outcomes for 49 HPB operations from 1 January 2005 through 31 December 2007. The procedures included six hepatic, 16 pancreatic and 23 complex biliary operations. Four laparoscopic or open cholecystectomy operations were also studied. Risk-adjusted probabilities for morbidity and mortality were compared with observed rates for each operation. RESULTS: During this 36-month period, data were accumulated on 9723 patients who underwent major HPB surgery, as well as on 44,189 who received cholecystectomies. The major HPB operations included 2847 hepatic (29%), 5074 pancreatic (52%) and 1802 complex biliary (19%) procedures. Patients undergoing hepatic resections were more likely to have metastatic disease (42%) and recent chemotherapy (7%), whereas those undergoing complex biliary procedures were more likely to have significant weight loss (20%), diabetes (13%) and ascites (5%). Morbidity was high for hepatic, pancreatic and complex biliary operations (20.1%, 32.4% and 21.2%, respectively), whereas mortality was low (2.3%, 2.7% and 2.7%, respectively). Compared with laparoscopic cholecystectomy, the open operation was associated with higher rates of morbidity (19.2% vs. 6.0%) and mortality (2.5% vs. 0.3%). The ratios between observed and expected morbidity and mortality rates were <1.0 for hepatic, pancreatic and biliary operations. CONCLUSIONS: These data suggest that HPB operations performed at ACS-NSQIP hospitals have acceptable outcomes. However, the creation of an HPB-NSQIP has the potential to improve quality, provide risk-adjusted registries with HPB-specific data and facilitate multi-institutional clinical trials.
Authors: Justin B Dimick; Reid M Wainess; John A Cowan; Gilbert R Upchurch; James A Knol; Lisa M Colletti Journal: J Am Coll Surg Date: 2004-07 Impact factor: 6.113
Authors: J Daley; S F Khuri; W Henderson; K Hur; J O Gibbs; G Barbour; J Demakis; G Irvin; J F Stremple; F Grover; G McDonald; E Passaro; P J Fabri; J Spencer; K Hammermeister; J B Aust; C Oprian Journal: J Am Coll Surg Date: 1997-10 Impact factor: 6.113
Authors: Attila Nakeeb; Khoi Q Tran; Michael J Black; Beth A Erickson; Paul S Ritch; Edward J Quebbeman; Stuart D Wilson; Michael J Demeure; William S Rilling; Kulwinder S Dua; Henry A Pitt Journal: Surgery Date: 2002-10 Impact factor: 3.982
Authors: Ronnie T Poon; Sheung Tat Fan; Chung Mau Lo; Chi Leung Liu; Chi Ming Lam; Wai Key Yuen; Chun Yeung; John Wong Journal: Ann Surg Date: 2004-10 Impact factor: 12.969
Authors: A Nakeeb; H A Pitt; T A Sohn; J Coleman; R A Abrams; S Piantadosi; R H Hruban; K D Lillemoe; C J Yeo; J L Cameron Journal: Ann Surg Date: 1996-10 Impact factor: 12.969
Authors: Kevin G Billingsley; Kwan Hur; William G Henderson; Jennifer Daley; Shukri F Khuri; Richard H Bell Journal: J Gastrointest Surg Date: 2003 May-Jun Impact factor: 3.452
Authors: J A Sosa; H M Bowman; T A Gordon; E B Bass; C J Yeo; K D Lillemoe; H A Pitt; J M Tielsch; J L Cameron Journal: Ann Surg Date: 1998-09 Impact factor: 12.969
Authors: John D Birkmeyer; Therese A Stukel; Andrea E Siewers; Philip P Goodney; David E Wennberg; F Lee Lucas Journal: N Engl J Med Date: 2003-11-27 Impact factor: 91.245
Authors: S F Khuri; J Daley; W Henderson; G Barbour; P Lowry; G Irvin; J Gibbs; F Grover; K Hammermeister; J F Stremple Journal: J Am Coll Surg Date: 1995-05 Impact factor: 6.113
Authors: Peter J Kneuertz; Henry A Pitt; Karl Y Bilimoria; Jill P Smiley; Mark E Cohen; Clifford Y Ko; Timothy M Pawlik Journal: J Gastrointest Surg Date: 2012-07-04 Impact factor: 3.452
Authors: Purvi Parikh; Mira Shiloach; Mark E Cohen; Karl Y Bilimoria; Clifford Y Ko; Bruce L Hall; Henry A Pitt Journal: HPB (Oxford) Date: 2010-09 Impact factor: 3.647
Authors: Ching-Wei D Tzeng; Matthew H G Katz; Jason B Fleming; Jeffrey E Lee; Peter W T Pisters; Holly M Holmes; Gauri R Varadhachary; Robert A Wolff; James L Abbruzzese; Jean-Nicolas Vauthey; Thomas A Aloia Journal: J Gastrointest Surg Date: 2013-10-16 Impact factor: 3.452
Authors: Ching-Wei D Tzeng; Amanda B Cooper; Jean-Nicolas Vauthey; Steven A Curley; Thomas A Aloia Journal: HPB (Oxford) Date: 2013-08-26 Impact factor: 3.647
Authors: Irene Epelboym; Irmina Gawlas; James A Lee; Beth Schrope; John A Chabot; John D Allendorf Journal: World J Surg Date: 2014-06 Impact factor: 3.352
Authors: Jashodeep Datta; Russell S Lewis; Steven M Strasberg; Bruce L Hall; John D Allendorf; Joal D Beane; Stephen W Behrman; Mark P Callery; John D Christein; Jeffrey A Drebin; Irene Epelboym; Jin He; Henry A Pitt; Emily Winslow; Christopher Wolfgang; Major K Lee; Charles M Vollmer Journal: J Gastrointest Surg Date: 2014-12-02 Impact factor: 3.452
Authors: Nina P Tamirisa; Abhishek D Parmar; Gabriela M Vargas; Hemalkumar B Mehta; E Molly Kilbane; Bruce L Hall; Henry A Pitt; Taylor S Riall Journal: Ann Surg Date: 2016-02 Impact factor: 12.969
Authors: Amanda B Cooper; Abhishek D Parmar; Taylor S Riall; Bruce L Hall; Matthew H G Katz; Thomas A Aloia; Henry A Pitt Journal: J Gastrointest Surg Date: 2014-08-05 Impact factor: 3.452